Schmidt, A. L., Labaki, C., Hsu, C.-Y., Bakouny, Z., Balanchivadze, N., Berg, S. A., Blau, S., Daher, A., El Zarif, T., Friese, C. R., Griffiths, E. A., Hawley, J. E., Hayes-Lattin, B., Karivedu, V., Latif, T., Mavromatis, B. H., McKay, R. R., Nagaraj, G., Nguyen, R. H., … Warner, J. L. (2022). COVID-19 vaccination and breakthrough infections in patients with cancer. Annals of Oncology, 33(3), 340–346. https://doi.org/10.1016/j.annonc.2021.12.006

Kochanek, M., Kochanek, J., Böll, B., Eichenauer, D. A., Beutel, G., Bracht, H., Braune, S., Eisner, F., Friesecke, S., Günther, U., Heinz, G., Hallek, M., Karagiannidis, C., Kluge, S., Kogelmann, K., Lebiedz, P., Lepper, P. M., Liebregts, T., Lueck, C., … Shimabukuro-Vornhagen, A. (2022). Veno-venous extracorporeal membrane oxygenation (vv-ECMO) for severe respiratory failure in adult cancer patients: a retrospective multicenter analysis. Intensive Care Medicine, 48(3), 332–342. https://doi.org/10.1007/s00134-022-06635-y

Maniar, A., Haslam, A., & Prasad, V. (2022). Evaluating management of progressive disease for control arm patients in trials of first line PD-1 or PD-L1 inhibitor-based treatment for metastatic solid tumours. European Journal of Cancer, 164, 95–104. https://doi.org/10.1016/j.ejca.2022.01.006

Shirazian, S., Starakiewicz, P., & Latcha, S. (2021). Cancer Screening in End-Stage Kidney Disease. Advances in Chronic Kidney Disease, 28(5), 502-508.e1. https://doi.org/10.1053/j.ackd.2021.09.006

Powers, J. A., & Chio, I. I. C. (2022). Softening redox homeostasis in cancer cells. Nature Cell Biology, 24(2), 133–134. https://doi.org/10.1038/s41556-022-00845-8

Kishore, S. A., Bajwa, R., Van Doren, L., Wilkins, C., & O’Sullivan, G. J. (2022). Endovascular Management of Venous Thromboembolic Disease in the Oncologic Patient Population. Current Oncology Reports, 24(3), 351–362. https://doi.org/10.1007/s11912-022-01191-6

Menolfi, D., & Zha, S. (2021). Targeting BRCA-mutated tumors in mitosis. Nature Cancer, 2(12), 1296–1297. https://doi.org/10.1038/s43018-021-00293-7

Shi, D. D., Guo, J. A., Hoffman, H. I., Su, J., Mino-Kenudson, M., Barth, J. L., Schenkel, J. M., Loeffler, J. S., Shih, H. A., Hong, T. S., Wo, J. Y., Aguirre, A. J., Jacks, T., Zheng, L., Wen, P. Y., Wang, T. C., & Hwang, W. L. (2022). Therapeutic avenues for cancer neuroscience: translational frontiers and clinical opportunities. The Lancet Oncology, 23(2), e62–e74. https://doi.org/10.1016/s1470-2045(21)00596-9

Douglass, E. F., Allaway, R. J., Szalai, B., Wang, W., Tian, T., Fernández-Torras, A., Realubit, R., Karan, C., Zheng, S., Pessia, A., Tanoli, Z., Jafari, M., Wan, F., Li, S., Xiong, Y., Duran-Frigola, M., Bertoni, M., Badia-i-Mompel, P., Mateo, L., … Califano, A. (2022). A community challenge for a pancancer drug mechanism of action inference from perturbational profile data. Cell Reports Medicine, 3(1), 100492. https://doi.org/10.1016/j.xcrm.2021.100492

Schöffski, P., Tan, D. S. W., Martín, M., Ochoa-de-Olza, M., Sarantopoulos, J., Carvajal, R. D., Kyi, C., Esaki, T., Prawira, A., Akerley, W., De Braud, F., Hui, R., Zhang, T., Soo, R. A., Maur, M., Weickhardt, A., Krauss, J., Deschler-Baier, B., Lau, A., … Hong, D. S. (2022). Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies. Journal for ImmunoTherapy of Cancer, 10(2), e003776. https://doi.org/10.1136/jitc-2021-003776

Liu, Y., & Gu, W. (2022). p53 in ferroptosis regulation: the new weapon for the old guardian. Cell Death & Differentiation, 29(5), 895–910. https://doi.org/10.1038/s41418-022-00943-y

Zhang, H. (2022). Cancer Pain Management—New Therapies. Current Oncology Reports, 24(2), 223–226. https://doi.org/10.1007/s11912-021-01166-z

Kuo, C.-C., Balakrishnan, P., Gribble, M. O., Best, L. G., Goessler, W., Umans, J. G., & Navas-Acien, A. (2022). The association of arsenic exposure and arsenic metabolism with all-cause, cardiovascular and cancer mortality in the Strong Heart Study. Environment International, 159, 107029. https://doi.org/10.1016/j.envint.2021.107029

Christin, J. R., & Shen, M. M. (2022). Modeling tumor plasticity in organoid models of human cancer. Trends in Cancer, 8(3), 161–163. https://doi.org/10.1016/j.trecan.2021.12.004

Abbasian Ardakani, A., Bureau, N. J., Ciaccio, E. J., & Acharya, U. R. (2022). Interpretation of radiomics features–A pictorial review. Computer Methods and Programs in Biomedicine, 215, 106609. https://doi.org/10.1016/j.cmpb.2021.106609

Hawley, J. E., Sun, T., Chism, D. D., Duma, N., Fu, J. C., Gatson, N. T. N., Mishra, S., Nguyen, R. H., Reid, S. A., Serrano, O. K., Singh, S. R. K., Venepalli, N. K., Bakouny, Z., Bashir, B., Bilen, M. A., Caimi, P. F., Choueiri, T. K., Dawsey, S. J., Fecher, L. A., … Stratton, C. (2022). Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States. JAMA Network Open, 5(1), e2142046. https://doi.org/10.1001/jamanetworkopen.2021.42046

Heaney, M. L. (2022). Can the treatment of myeloproliferative neoplasms be both good and bad for you? The Lancet Haematology, 9(1), e3–e4. https://doi.org/10.1016/s2352-3026(21)00371-9

Ayton, S. G., Pavlicova, M., Robles-Espinoza, C. D., Tamez Peña, J. G., & Treviño, V. (2022). Multiomics subtyping for clinically prognostic cancer subtypes and personalized therapy: A systematic review and meta-analysis. Genetics in Medicine, 24(1), 15–25. https://doi.org/10.1016/j.gim.2021.09.006

Cossarizza, A., Chang, H., Radbruch, A., Abrignani, S., Addo, R., Akdis, M., Andrä, I., Andreata, F., Annunziato, F., Arranz, E., Bacher, P., Bari, S., Barnaba, V., Barros‐Martins, J., Baumjohann, D., Beccaria, C. G., Bernardo, D., Boardman, D. A., Borger, J., … Yang, J. (2021). Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition). European Journal of Immunology, 51(12), 2708–3145. Portico. https://doi.org/10.1002/eji.202170126

Cable, J., Pei, D., Reid, L. M., Wang, X. W., Bhatia, S., Karras, P., Melenhorst, J. J., Grompe, M., Lathia, J. D., Song, E., Kuo, C. J., Zhang, N., White, R. M., Ma, S. K., Ma, L., Chin, Y. R., Shen, M. M., Ng, I. O. L., Kaestner, K. H., … Weissman, I. L. (2021). Cancer stem cells: advances in biology and clinical translation—a Keystone Symposia report. Annals of the New York Academy of Sciences, 1506(1), 142–163. Portico. https://doi.org/10.1111/nyas.14719